LD-2 disclosure · 1st Quarter - Termination (No Activity)
ULTRAGENYX PHARMACEUTICAL
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Clinical-stage biotechnology company focused on debilitating metabolic genetic diseases.
- Location
- California · United States of America
Registrant
- Description
- lobby firm
- Location
- Washington, District of Columbia, United States of America